New Research Reveals Impact of COVID-19 on Attitudes to Virtual Healthcare

VisionableHospitals face new demand for virtual visiting, and more patients are confident they don't always need to see a doctor in person, as the use of remote technologies rise. But concerns around data security and privacy are voiced, and people with lower incomes are more likely to express anxieties about the virtual shift, new research commissioned by health tech company Visionable has revealed.

Nearly three quarters of patients believe they don't always need to see a doctor in person to receive appropriate care, following the initial spread of coronavirus in the UK, and many more people are urging hospitals to facilitate virtual visiting of friends and loved ones.

These are just two of the findings revealed today in a new report from health tech company Visionable, that shows the impact of COVID-19 on public attitudes to communications technology in healthcare.

The report is based on two rounds of research that each surveyed approximately 1,500 people - one in February 2020, just ahead of the initial escalation of COVID-19 cases in the UK, and a second carried out in May with a near identical demographic sample, in order to measure any shifts in perceptions and experience of communications technology within healthcare following the national lockdown ordered in March.

The report confirms assumptions around increased usage of remote technologies, and also sheds new light around a number of concerns - including women being more likely to be apprehensive about showing body parts, and people with lower incomes being more likely to express concerns around interacting with healthcare professionals virtually.

Highlights from the report include:

  • 73% of people questioned in May agreed they did not always need to see a doctor in person to receive appropriate care (compared to 62% in February).
  • Three quarters of patients in May said they were happy to use video to engage their GP, compared with 62% previously in February.
  • The number of people questioned who had experienced some form of remote consultation (eg phone or video) rose from 51% in February to 63% in May. There was a 50% rise in respondents who had experienced a video consultation (from 8% to 12%). And four in 10 people with chronic conditions had experienced a video consultation, by May. 88% of people with chronic conditions who responded had experienced a remote consultation of some sort by May.
  • New demand for virtual visiting of friends and loved ones in hospital emerged. Fewer than three in 10 people questioned in May said they were comfortable physically visiting someone in hospital. 82% of respondents thought it was fairly or extremely important for their hospital to allow video technology to enable virtual visiting.
  • More than half - 54% of respondents - said that data security was a potential concern, whilst a very similar amount - 53% - were concerned about making mistakes through technology.
  • Showing body parts: 45% of respondents said they were less inclined to show body parts through communications technology than in person.
  • Income appeared to affect appetite for virtual technologies and concerns. For example the percentage of people very or fairly happy to have a video consultation with a GP by May was found to be 90% of respondents on higher income (avg £89,000), 75% of those on a mid-income (avg £38,000), and 68% of people on lower income (avg £16,000).

Nina Vinall, Chief Clinical Officer for Visionable, said: "This report has tested the temperature of the public on the use of remote technology in healthcare at a time when that technology has become important in enabling patients access to healthcare professionals.

"It asks some important questions and highlights a number of useful insights into the acceptance of virtual technologies that need to be carefully considered if we are to ensure services remain accessible to patients and equitable for all. This research is not intended as a comprehensive end point in our understanding of patient requirements - it is a starting point that raises ideas and topic areas for ongoing research."

A full copy of the research whitepaper can be found here: https://visionable.com/whitepaper/

About Visionable

Visionable is a healthcare technology company that provides a universal video collaboration platform for clinicians to deliver better patient care. Designed by founders who have worked within the NHS and who continue to partner closely with NHS clinicians, the platform has been built specifically to address the advanced technical needs found in healthcare. To achieve a truly 'connected health' system, Visionable makes it easy for everyone - from clinicians to whole organisations - to work together, ensuring patients’ access to the timeliest, best care possible.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...